CORRELATIONS BETWEEN PRO-INFLAMMATORY MARKERS AND GLYCATED HEMOGLOBIN IN TYPE 2 DIABETES PATIENTS
Journal Title: Romanian Journal of Diabetes Nutrition and Metabolic Diseases - Year 2011, Vol 18, Issue 4
Abstract
Background and Aim. Markers of inflammation are predictive of diabetic macrovascular complications. In type 2 diabetes, inflammation might be responsible for enhancing insulin resistance and may contribute to the reduction of islet cells secretory function. In the present study, we investigated the correlation between the pro-inflammatory markers and glycated hemoglobin in patients with type 2 diabetes mellitus. Materials and Methods. 66 patients (32 women and 34 men) with type 2 diabetes were recruited for this study. On fasting plasma samples C-reactive protein, interleukin-6, tumor necrosis factor-α (TNF-α) and glycated hemoglobin (HbA1c) were assayed. C-reactive protein, interleukin-6 and TNF-α were measured using enzyme-linked immunosorbent assays. The HbA1c were measured using a high-performance liquid chromatography method. Results were compared to the corresponding parameters obtained for 38 subjects (18 women and 20 men) without type 2 diabetes (control group). Results. The groups were similar in terms of age and sex but there were statistically significant differences in the recorded parameters in diabetic patients compared to the control group. Circulating levels of C-reactive protein, interleukin-6, TNF-α and HbA1c were higher (p<0.05) in patients with type 2 diabetes mellitus compared to normally metabolic patients. In the patients with type 2 diabetes mellitus HbA1c were significantly correlated with circulating C-reactive protein (r=0.909, p<0.001) and interleukin-6 (r=0.883, p<0.001) levels. Conclusion. The markers of inflammation are significantly higher in patients with type 2 diabetes compared to subjects without diabetes. The elevated markers of inflammation (C-reactive protein and interleukin-6) were significantly correlated with glycemic control (HbA1c).
Authors and Affiliations
Rucsandra Dănciulescu Miulescu, Denisa Margina, Marlena Pascu, Sorin Paun
Keywords
Related Articles
- EP ID EP160854
- DOI -
- Views 112
- Downloads 0
CORRELATIONS BETWEEN PRO-INFLAMMATORY MARKERS AND GLYCATED HEMOGLOBIN IN TYPE 2 DIABETES PATIENTS
Background and Aim. Markers of inflammation are predictive of diabetic macrovascular complications. In type 2 diabetes, inflammation might be responsible for enhancing insulin resistance and may contribute to the reducti...
HEPATIC FIBROSIS, MEASURED BY FIBROSCANIN A GROUP OF PATIENTS WITH OBESITY
Introduction. Hepatic steatosis is a reversible condition caused by accumulation of triglycerides in liver cells. Non-alcoholic fatty liver disease (NAFLD) can progress to advanced liver disease: fibrosis, cirrhosi...
SUBCUTIS DYSTROPHY IN INSULIN TREATED CIRRHOTIC PATIENT
Insulin injections can induce local dystrophies. Many reasons can be but, the most common is the same area repeatedly injected. Our subject is a 50-year-old man insulin treated, also being under medical survey because of...
PATHOGENESIS OF TYPE 1 DIABETES MELLITUS: A BRIEF OVERVIEW
Before the discovery of insulin, type 1 diabetes mellitus (DM) was a disease with acute evolution, leading to death shortly after diagnosis. During the first years of insulin therapy, the medical world was optimist...
Therapeutical Options For Optimizing The Glycemic Profile In A Patient With T2DM
Incretin-based therapies address some of the mechanisms of T2DM by improving β-cell function, inhibiting glucagon secretion, stimulating insulin secretion, reducing appetite and promoting weight loss. We present the case...